Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1991 1
1992 1
1995 1
2004 1
2007 1
2008 2
2010 1
2011 3
2012 5
2014 2
2015 1
2016 1
2017 1
2021 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
PP-Why?
Jury R, Emkes J, Bovis M, Spencer B, de Winter L, Kulkarni M. Jury R, et al. BJU Int. 2021 Mar;127(3):384-387. doi: 10.1111/bju.15359. BJU Int. 2021. PMID: 33630418 No abstract available.
The significance of Trk receptors in pancreatic cancer.
Johnson MD, Stone B, Thibodeau BJ, Baschnagel AM, Galoforo S, Fortier LE, Ketelsen B, Ahmed S, Kelley Z, Hana A, Wilson TG, Robertson JM, Jury RP, Wilson GD. Johnson MD, et al. Among authors: jury rp. Tumour Biol. 2017 Feb;39(2):1010428317692256. doi: 10.1177/1010428317692256. Tumour Biol. 2017. PMID: 28218045 Free article.
Phase I study of conformal radiotherapy and concurrent full-dose gemcitabine with erlotinib for unresected pancreatic cancer.
Robertson JM, Margolis J, Jury RP, Balaraman S, Cotant MB, Ballouz S, Boxwala IG, Jaiyesimi IA, Nadeau L, Hardy-Carlson M, Marvin KS, Wallace M, Ye H. Robertson JM, et al. Among authors: jury rp. Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e187-92. doi: 10.1016/j.ijrobp.2010.08.050. Epub 2011 May 5. Int J Radiat Oncol Biol Phys. 2012. PMID: 21549514 Clinical Trial.
22 results